Drug Shortage Report for ONIVYDE
| Report ID | 191665 |
| Drug Identification Number | 02467135 |
| Brand name | ONIVYDE |
| Common or Proper name | IRINOTECAN |
| Company Name | IPSEN BIOPHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRINOTECAN |
| Strength(s) | 4.3MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 43mg/10mL |
| ATC code | L01CE |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2023-07-06 |
| Estimated end date | Unknown |
| Actual end date | 2023-08-18 |
| Shortage status | Resolved |
| Updated date | 2023-08-22 |
| Company comments | Business reasons |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 5050 SATELLITE DRIVE MISSISSAUGA, ONTARIO CANADA L4W 0G1 |
| Company contact information | medinfoandsafetycanada@ipsen.com 1(855) 215-2288 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2023-08-22 | French | Compare |
| v11 | 2023-08-22 | English | Compare |
| v10 | 2023-07-10 | French | Compare |
| v9 | 2023-07-10 | English | Compare |
| v8 | 2023-07-10 | French | Compare |
| v7 | 2023-07-10 | English | Compare |
| v6 | 2023-05-08 | French | Compare |
| v5 | 2023-05-08 | English | Compare |
| v4 | 2023-05-08 | English | Compare |
| v3 | 2023-05-08 | French | Compare |
| v2 | 2023-05-08 | English | Compare |
| v1 | 2023-05-04 | English | Compare |
Showing 1 to 12 of 12